Page last updated: 2024-10-29

ketamine and Intracranial Arteriovenous Malformations

ketamine has been researched along with Intracranial Arteriovenous Malformations in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Intracranial Arteriovenous Malformations: Congenital vascular anomalies in the brain characterized by direct communication between an artery and a vein without passing through the CAPILLARIES. The locations and size of the shunts determine the symptoms including HEADACHES; SEIZURES; STROKE; INTRACRANIAL HEMORRHAGES; mass effect; and vascular steal effect.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, SP1
Abdi, S1

Other Studies

1 other study available for ketamine and Intracranial Arteriovenous Malformations

ArticleYear
Venous malformations associated with central pain: report of a case.
    Anesthesia and analgesia, 2002, Volume: 95, Issue:5

    Topics: Analgesics, Opioid; Dextromethorphan; Excitatory Amino Acid Antagonists; Female; Humans; Intracrania

2002